Skip to content

Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach

Machine Learning Analysis Of The Tapping Test And The Archimedean Spiral For The Differential Diagnosis Of Essential Tremor And Parkinson's Disease.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06378619
Acronym
MATSEP
Enrollment
110
Registered
2024-04-22
Start date
2024-07-15
Completion date
2026-07-31
Last updated
2025-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Tremor, Parkinson Disease, Tremor

Keywords

Tremor, Essential Tremor, Parkinson Disease, Diagnosis, Differential, Machine Learning

Brief summary

In clinical practice, it is sometimes difficult to establish whether a patient's tremor is due to Parkinson's disease or essential tremor. The distinction is crucial as the health implications differ significantly between the two conditions. Therefore, the present study aims to develop a diagnostic method based on machine learning techniques to help differentiate whether a patient's tremor is due to one condition or the other. To achieve this, 110 patients with tremor, correctly diagnosed with either Parkinson's disease or essential tremor, will participate. They will undergo two diagnostic tests (tapping test and Archimedean spiral) to capture data that can be processed using machine learning techniques.

Interventions

DIAGNOSTIC_TESTTapping Test

For the administration of the tapping test, a computer application installed on a Tablet will be used. The test will be administered up to 3 times, with a 15-minute interval between each administration. Each tapping test trial will last 15 seconds. At the beginning of the session, the patient will perform 2 practice attempts.

DIAGNOSTIC_TESTArchimedes Spiral

For the administration of the Archimedean spiral, a computer application installed on a Tablet will be used. The Tablet screen will display a drawing of the spiral, serving as a reference for the participant. The test will be administered up to 3 times, with a 15-minute interval between each administration. At the beginning of the session, the patient will perform 2 practice attempts.

Sponsors

Consorci Sanitari de l'Alt Penedès i Garraf
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Possibility to collaborate in the necessary evaluations. * Follow-up in the specialized consultation of Movement Disorders at the Neurology Service of Hospital Sant Camil-Consorci Sanitari Alt Penedes i Garraf. * Legal capacity to provide informed consent. * Signature of informed consent for study inclusion, either by the participant themselves or by their legal representative. * Participant with criteria from Group 1 or 2: Group 1: * Confirmed diagnosis of tremor due to Parkinson's disease, clinically established, based on the diagnostic criteria of the Movement Disorders Society, and additionally: * Tremor associated with bradykinesia of any duration. * Confirmatory clinical diagnosis of tremor due to Parkinson's disease (stages 1 to 2 of Hoehn and Yahr) by the neurologist responsible for the participant's follow-up. Group 2: * Confirmed diagnosis of essential tremor, based on the criteria of the Movement Disorders Society, and additionally: * Positional tremor plus kinetic and/or resting tremor with follow-up in outpatient neurology consultations for at least 3 years without a change in diagnosis. * Absence of bradykinesia.

Exclusion criteria

* Patients undergoing treatment with antipsychotics or antidepressants. * Patients with Parkinson's disease and dyskinesias. * Patients undergoing treatment with dopaminergic agonists or primidone. * Tremor of such severity that it prevents continuous tracing, at the investigator's discretion. * Cognitive or affective pathology that limits the ability to collaborate with the study procedures. * Participation in another clinical study involving an intervention, procedure, or visit frequency that is incompatible with the present study. * Participants diagnosed with any of the following conditions: Alcoholism of sufficient intensity to influence handwriting or cause neuropathy, at the investigator's discretion. Peripheral neuropathy of any cause. Dystonias. Previous stroke.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivitythrough study completion, an average of 1 yearProportion of participants with confirmed Parkinson's disease for whom the machine learning-based diagnostic algorithm yields a 'positive' result.
Specificitythrough study completion, an average of 1 yearProportion of participants with confirmed essential tremor for whom the machine learning-based diagnostic algorithm yields a 'negative' result.

Secondary

MeasureTime frameDescription
Reliabilitythrough study completion, an average of 1 yearThe reliability of the diagnostic algorithm will be evaluated based on the repeatability of the classification result (positive or negative) among the different tests conducted on the same patient

Countries

Spain

Contacts

Primary ContactJosé Luis Camacho, MD
jlcamacho@csapg.cat+34 938960025
Backup ContactNoemí Casaponsa
recerca@csapg.cat+34 938960025

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026